SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-057743
Filing Date
2023-11-02
Accepted
2023-11-02 07:15:29
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q kymr-20230930.htm   iXBRL 10-Q 3051260
2 EX-31.1 kymr-ex31_1.htm EX-31.1 18852
3 EX-31.2 kymr-ex31_2.htm EX-31.2 18699
4 EX-32.1 kymr-ex32_1.htm EX-32.1 10622
5 EX-32.2 kymr-ex32_2.htm EX-32.2 10472
  Complete submission text file 0000950170-23-057743.txt   10742357

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kymr-20230930_pre.xml EX-101.PRE 381401
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kymr-20230930.xsd EX-101.SCH 68012
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kymr-20230930_def.xml EX-101.DEF 240833
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kymr-20230930_lab.xml EX-101.LAB 543661
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kymr-20230930_cal.xml EX-101.CAL 52906
68 EXTRACTED XBRL INSTANCE DOCUMENT kymr-20230930_htm.xml XML 2072598
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39460 | Film No.: 231370057
SIC: 2836 Biological Products, (No Diagnostic Substances)